# Inhibikase Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2024

- Company: [Inhibikase Therapeutics, Inc.](/companies/ikt.md) (CIK 1750149)
- Form: 10-K/A
- Filed: 2025-04-25
- Accepted by EDGAR: Apr 25, 2025, 20:05 ET
- Period: 2024-12-31
- Accession: 0000950170-25-058693
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750149/000095017025058693/ikt-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750149/000095017025058693/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1750149/000095017025058693/ikt-20241231.htm

Filed Apr 25, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-058693. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.